Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-01-04 @ 7:57 AM
Study NCT ID:
NCT03178851
Status:
COMPLETED
Last Update Posted:
2021-11-19
First Post:
2017-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-21
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-01
First Submit QC Date:
None
Study First Post Date:
2017-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-05-06
Results First Submit QC Date:
None
Results First Post Date:
2020-06-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-17
Last Update Post Date:
2021-11-19
Last Update Post Date Type:
ACTUAL